Our goal: develop innovative molecular diagnostic solutions to advance the diagnosis of infectious diseases and antibiotic resistances
Mobidiag, A Hologic Company, is a fast-growing Finnish-French biotechnology company. At Mobidiag, we develop and market innovative molecular diagnostic solutions for Gastrointestinal Infections, Antimicrobial Resistance Management, Healthcare Associated Infections (HAIs), Respiratory Infections and Sepsis.
Based on well-established qPCR and microarray technologies, Mobidiag offers a broad range of tests and automated platforms. These include a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases adapted to laboratories of all sizes. They allow detection of most clinically relevant bacteria, parasites, viruses and antibiotic resistances.
Established in 2000, Mobidiag has started serving the European clinical diagnostics market with the multiplex Prove-it™ product family (now discontinued).
In 2013, Mobidiag (Finland) merged with a diagnostic platform developer Genewave (France) and a stool-based clinical assay development company Amplidiag (Finland). As a result, complementing capabilities and offering were gathered to offer industry-leading and innovative molecular diagnostic solutions.
Combining expertise in sales, marketing, business, molecular diagnostics, microbiology, software development, bioinformatics, biochemistry and engineering, Mobidiag is able to manufacture and commercialise its own proprietary solutions: Amplidiag® and Novodiag®.
Our mission at Mobidiag
At Mobidiag, we work to address the unmet need for high information-density, easy to use and affordable innovative molecular diagnostic solutions. We strive to enable the rapid treatment and triage of patients at the point of impact. Overall, we want to improve the quality and efficiency of healthcare and aid in the combat against the emerging and spreading of antimicrobial resistances. In order to do so, we work closely with distinguished clinical, academic and industrial partners to deliver the most relevant and highest-value solutions to our customers throughout the world.
At Mobidiag, we are very proud to have shown great responsiveness in the development of new COVID-19 tests in an emergency situation. Learn more about how we successfully participate in the fight against coronavirus.
Mobidiag, part of a dynamic and innovative ecosystem
Mobidiag headquarters are located in the largest innovation hub in the Nordic countries, the city of Espoo, which aims at solving the challenges of a sustainable future, and create new smart services and jobs.
Home of Nokia, Kone, VTT Technical Research Centre of Finland, Angry Birds and many more high-tech companies, Mobidiag has been able to grow in a dynamic ecosystem and partner with leaders in the field to bring state-of-the-art technologies.